Vanda Pharmaceuticals, Inc. (VNDA)
5.76
-0.34
(-5.57%)
USD |
NASDAQ |
Feb 20, 16:00
8.30
+2.54
(+44.10%)
After-Hours: 20:00
Vanda Pharmaceuticals Profit Margin (Quarterly) : -246.8% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 34.40% |
| AbbVie, Inc. | 10.92% |
| Axsome Therapeutics, Inc. | -27.62% |
| AnaptysBio, Inc. | 19.80% |
| SELLAS Life Sciences Group, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -47.32% |
| Return on Assets | -36.71% |
| Return on Invested Capital | -46.15% |
| Gross Profit Margin (Quarterly) | 86.65% |
| Operating Margin (Quarterly) | -70.53% |
| Return on Net Operating Assets | -124.0% |